Akhtar, Saeed
Al-Hashel, Jasem Y.
Alroughani, Raed
Article History
Received: 14 December 2022
Accepted: 20 June 2023
First Online: 5 July 2023
Declarations
:
: The patients with MS gave initially their informed consent for inclusion in the Kuwait National Multiple Sclerosis Registry and the use of their deidentified information for research purpose. The study was approved by the Research Committee of the Audit and Planning Office, Ministry of Health under a decree of 1670/2021. Furthermore, the study was also approved by the Ethics Committee, Health Sciences Center, Kuwait University. The study was conducted in accordance with the principles and guidelines of the Declaration of Helsinki for medical research involving human subjects. Furthermore, the methods including design, conduct, data collection, analysis and reporting of the results conformed with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines.
: Not applicable.
: The authors declare no competing interests.
: The abstract of this study was presented as a poster in Annual Conference of Society for Epidemiologic Research (USA) held at Chicago IL, USA on June 14–17, 2022.